Cargando…
Polymorphisms Affecting the Response to Novel Antiepileptic Drugs
Epilepsy is one of the most frequent chronic neurologic disorders that affects nearly 1% of the population worldwide, especially in developing countries. Currently, several antiepileptic drugs (AEDs) are available for its therapy, and although the prognosis is good for most patients, 20%–30% amongst...
Autores principales: | Urzì Brancati, Valentina, Pinto Vraca, Tiziana, Minutoli, Letteria, Pallio, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917302/ https://www.ncbi.nlm.nih.gov/pubmed/36768858 http://dx.doi.org/10.3390/ijms24032535 |
Ejemplares similares
-
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
por: Urzì Brancati, Valentina, et al.
Publicado: (2022) -
Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment
por: Brancati, Valentina Urzì, et al.
Publicado: (2023) -
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
por: Irrera, Natasha, et al.
Publicado: (2020) -
Nutraceuticals as Alternative Approach against Cadmium-Induced Kidney Damage: A Narrative Review
por: Marini, Herbert Ryan, et al.
Publicado: (2023) -
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
por: Saruwatari, Junji, et al.
Publicado: (2010)